January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
In people with PA and no concerning features, treatment with high-dose oral B12 or injection B12 are both reasonable options.
A person who has the type of anemia with B12 deficiency and low B12 levels (called "megaloblastic anemia" with unusual white ...
Dear M.P.: Pernicious anemia (PA) is an autoimmune disease where the body destroys the cells in the stomach that make ...
Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...
Researchers have a new hope for preventing severe illness from the bird flu after finding a groundbreaking antibody treatment ...
8d
Verywell Health on MSNNew Maintenance Dosing Option for Alzheimer's Drug Leqembi Offers FlexibilityVerywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...
A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of ...
I am 71 years old and was diagnosed with pernicious anemia in October 2024. My B12 and folate levels were low. My antiparietal antibodies were abnormal, but the ...
"Modifying the sugar parts of the antibody doesn't seem to affect its overall structure or how it behaves, which is important when developing antibodies as a treatment." Monoclonal antibodies are ...
So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.
Hopkins researchers help secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to explore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results